Financial RecoveryAnticipated recovery with a significant narrowing of net loss, coupled with potential for share price appreciation due to key business catalysts.
Innovation And R&DMicroPort's commitment to innovation is evident through increased R&D investment, boosting its competitiveness on a global scale.
Market LeadershipLeader in China's drugs eluting stents industry with a dominant market share, expanding into new medical device categories.